SCHEMBL220625

SCHEMBL220625

C=C(C)C(=O)Oc1cccc(O)c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.68
ESR1 P03372 2/20 0.51
ESR2 Q92731 2/20 0.51
ELANE P08246 1/20 0.50
POLB P06746 1/20 0.47
LMNA P02545 2/20 0.44
KMT2A Q03164 3/20 0.43
ATM Q13315 1/20 0.43
MEN1 O00255 2/20 0.41
ACHE P22303 1/20 0.41
ALDH1A1 P00352 2/20 0.41
CYP1A2 P05177 1/20 0.41
CHRNB2 P17787 1/20 0.40
CHRNA4 P43681 1/20 0.40
CASP3 P42574 1/20 0.38
SENP8 Q96LD8 1/20 0.38
SENP7 Q9BQF6 1/20 0.38
SENP6 Q9GZR1 1/20 0.38
BCHE P06276 1/20 0.38
CA12 O43570 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31097939 1.00 CYP3A4 (0.68) CYP3A4ESR1ESR2ELANEPOLB
SCHEMBL218655 0.89 ELANE (0.56) CYP3A4ELANELMNAKMT2AATM
Resorcinol SCHEMBL11393699 0.85 ELANE (0.55) CYP3A4ESR1ESR2ELANEPOLB
SCHEMBL4928156 0.85 CYP3A4 (0.72) CYP3A4ESR1ESR2POLBLMNA
SCHEMBL379060 0.84 ELANE (0.51) CYP3A4ELANELMNAKMT2AATM
SCHEMBL26846471 0.84 LMNA (0.59) CYP3A4ELANELMNAKMT2AATM
SCHEMBL10787286 0.84 CYP3A4 (0.59) CYP3A4ESR1ESR2POLBLMNA
SCHEMBL14173262 0.84 ELANE (0.51) CYP3A4ELANEPOLBLMNAKMT2A
SCHEMBL7186457 0.82 CES2 (0.50) CYP3A4ESR1ESR2ELANELMNA
SCHEMBL1756084 0.82 CYP3A4 (0.50) CYP3A4ELANEPOLBLMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 656 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE41579-E1 Positive type photosensitive image-forming material for use with an infrared laser FUJIFILM CORPORATION (JP) 2010-08-24 US claimed
EP-1038668-B1 Photosensitive composition and planographic printing plate precursor using same FUJI PHOTO FILM CO LTD (JP) 2005-05-25 EP claimed
EP-0914964-B1 Positive type photosensitive composition for infrared lasers FUJI PHOTO FILM CO LTD (JP) 2004-12-29 EP claimed
EP-0909657-B1 A positive type photosensitive image-forming material for an infrared laser FUJI PHOTO FILM CO LTD (JP) 2003-06-18 EP claimed
US-20020081522-A1 Positive type photosensitive image-forming material for an infrared laser and a positive type photosensitive composition for an infrared laser FUJIFILM CORPORATION (JP) 2002-06-27 US claimed
US-6355396-B1 HIGH SENSITIVITY AND GOOD LATITUDE IN DEVELOPMENT, FOR PRODUCING DIRECT PLATE PRODUCTION PROCESS AND ENABLES AN IMAGE TO BE FORMED WITH HIGH SENSITIVITY WITH AN INFRARED LASER FUJI PHOTO FILM CO., LTD. (JP) 2002-03-12 US claimed
US-6340551-B1 ARE CAPABLE OF DIRECTLY MAKING A PRINTING PLATE USING AN INFRARED LASER BASED ON DIGITAL SIGNALS OUTPUTTED FROM A COMPUTER FUJI FILM CO., LTD. (JP) 2002-01-22 US claimed
US-6132929-A Positive type photosensitive composition for infrared lasers FUJI PHOTO FILM CO., LTD. (JP) 2000-10-17 US claimed
EP-1038668-A2 Photosensitive composition and planographic printing plate precursor using same FUJI PHOTO FILM CO., LTD. (JP) 2000-09-27 EP claimed
EP-0914964-A2 Positive type photosensitive composition for infrared lasers FUJI PHOTO FILM CO., LTD. (JP) 1999-05-12 EP claimed
EP-0909657-A2 A positive type photosensitive image-forming material for an infrared laser and a positive type photosensitive composition for an infrared laser FUJI PHOTO FILM CO., LTD (JP) 1999-04-21 EP claimed
EP-0066452-A2 Photosensitive composition for photosensitive printing plate KONICA CORPORATION (JP) 1982-12-08 EP claimed
US-12630795-B2 Cell culture substrate, method for producing cell culture substrate, and method for producing spheroids TOSOH CORPORATION (JP) 2026-05-19 US disclosed
US-20260084408-A1 POSITIVE TONE LITHOGRAPHIC PRINTING PLATE PRECURSOR AND METHOD OF PREPARING LITHOGRAPHIC PRINTING PLATE FUJIFILM CORPORATION (JP) 2026-03-26 US disclosed
EP-4714657-A1 POSITIVE-WORKING LITHOGRAPHIC PRINTING PLATE PRECURSOR AND METHOD OF PREPARING LITHOGRAPHIC PRINTING PLATE FUJIFILM Corporation (JP) 2026-03-25 EP disclosed
EP-4685230-A1 METHOD FOR PRODUCING NEURAL ORGANOIDS AND USE OF SAME KYOTO UNIVERSITY (JP) 2026-01-28 EP disclosed
WO-1998017644-A1 CROSS-LINKERS FOR CROSS-LINKABLE OPTICAL POLYCARBONATES AKZO NOBEL N.V. (NL) 1998-04-30 WO disclosed
US-5641577-A ROUGH SURFACE PREVENTING FROM ADHESION COMPRISING PROTRUSIONS ON PHOTORESIST COATINGS FUJI PHOTO FILM CO., LTD. (JP) 1997-06-24 US disclosed
EP-0730979-A2 Support for lithographic printing plate, process for the preparation thereof and electrochemical roughening apparatus FUJI PHOTO FILM CO., LTD. (JP) 1996-09-11 EP disclosed
EP-0672951-A2 Lead-frame forming material FUJI PHOTO FILM CO., LTD. (JP) 1995-09-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12630795-B2 Cell culture substrate, method for producing cell culture substrate, and method for producing spheroids MKI67, CCNB1, CD44 CYP3A4 4199/4885ESR1 3287/4885ESR2 1711/4885
US-20260084408-A1 POSITIVE TONE LITHOGRAPHIC PRINTING PLATE PRECURSOR AND METHOD OF PREPARING LITHOGRAPHIC PRINTING PLATE SUN2, LEF1, LCP1 CYP3A4 1572/4885ESR1 573/4885ESR2 1813/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.